BDTX Black Diamond Therapeutics, Inc.

Black Diamond Therapeutics, Inc. engages in the biotechnology company that discovers and develops therapeutic agents to target unique oncogenic protein-isoforms. The company was founded by Dr. David M. Epstein and Dr. Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

$2.62
As of 07/01/2022     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/30/2020
Outstanding shares:  36,290,901
Average volume:  338,681
Market cap:   $89,275,616
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BKTV702
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.55
PS ratio:   0.00
Return on equity:   2.71%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy